DanDrit Biotech USA, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 7/11/2016
Contact Info
  • Fruebjergvej 3 Box 62
  • Copenhagen 2100
  • Denmark

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001527728
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees 3 a/o Dec 21, 2014
Company Officers/Contacts
Dr. Eric Leire CEO
Lone Degn Former Officer
Company Directors
Niels Eric Nielsen Chairman
Dr. Eric Leire
Aldo Michael Noes Petersen
Service Providers
Accounting/Auditing Firm
Gregory & Associates, LLC
19 120th Street
Ocean City, MD, 21842
United States

Legal Counsel
K&L Gates LLP
200 S. Biscayne Blvd
Suite 3900
Miami, FL, 33131
United States

Investor Relations Firm
Wolfe Axelrod Weinberger Associates, LLC
One Grand Central Place
60 East 42nd Street
Suite 2534
New York, NY, 10165
United States

DDRT Security Details
Share Structure
Market Value1 $15,253,264 a/o Dec 05, 2016
Authorized Shares 100,000,000 a/o Sep 28, 2016
Outstanding Shares 9,533,290 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 7,402,528 a/o Sep 28, 2016
Par Value Not Available
Shareholders of Record 46 a/o Sep 28, 2016
Short Selling Data
Short Interest 0 (-100%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security